HCP’s (HCP) “Buy” Rating Reaffirmed at Stifel Nicolaus

HCP (NYSE:HCP)‘s stock had its “buy” rating restated by equities researchers at Stifel Nicolaus in a research report issued on Wednesday, MarketBeat Ratings reports. They currently have a $27.00 price objective on the real estate investment trust’s stock, down from their prior price objective of $29.00. Stifel Nicolaus’ price objective indicates a potential upside of 24.02% from the company’s previous close.

Other equities research analysts have also issued research reports about the company. Mizuho raised HCP from a “neutral” rating to a “buy” rating and set a $32.00 target price on the stock in a research note on Thursday, November 2nd. Morgan Stanley reissued an “equal weight” rating and set a $29.00 price target on shares of HCP in a research note on Thursday, December 14th. ValuEngine lowered HCP from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. Zacks Investment Research raised HCP from a “sell” rating to a “hold” rating in a research note on Thursday, November 9th. Finally, BMO Capital Markets reissued a “hold” rating and set a $28.00 price target on shares of HCP in a research note on Wednesday, October 18th. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $29.23.

Shares of HCP (HCP) opened at $21.77 on Wednesday. HCP has a 52 week low of $21.64 and a 52 week high of $33.67. The company has a quick ratio of 0.61, a current ratio of 0.61 and a debt-to-equity ratio of 1.17. The stock has a market capitalization of $10,703.31, a P/E ratio of 11.69, a P/E/G ratio of 4.16 and a beta of 0.27.

HCP (NYSE:HCP) last posted its earnings results on Tuesday, February 13th. The real estate investment trust reported $0.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.47 by $0.01. HCP had a return on equity of 6.87% and a net margin of 22.37%. The firm had revenue of $443.30 million for the quarter, compared to analyst estimates of $448.54 million. During the same quarter in the prior year, the company earned $0.59 EPS. HCP’s revenue was down 17.9% on a year-over-year basis. equities analysts forecast that HCP will post 1.83 earnings per share for the current year.

Hedge funds have recently added to or reduced their stakes in the company. Shell Asset Management Co. increased its holdings in shares of HCP by 311.9% during the 3rd quarter. Shell Asset Management Co. now owns 121,033 shares of the real estate investment trust’s stock worth $4,806,000 after buying an additional 91,652 shares during the last quarter. Sawyer & Company Inc acquired a new stake in shares of HCP during the 4th quarter worth $725,000. Beacon Investment Advisory Services Inc. increased its holdings in shares of HCP by 109.3% during the 3rd quarter. Beacon Investment Advisory Services Inc. now owns 18,570 shares of the real estate investment trust’s stock worth $517,000 after buying an additional 9,698 shares during the last quarter. California Public Employees Retirement System increased its holdings in shares of HCP by 3.9% during the 3rd quarter. California Public Employees Retirement System now owns 1,164,448 shares of the real estate investment trust’s stock worth $32,407,000 after buying an additional 43,888 shares during the last quarter. Finally, Arbor Wealth Management LLC increased its holdings in shares of HCP by 10.2% during the 3rd quarter. Arbor Wealth Management LLC now owns 146,389 shares of the real estate investment trust’s stock worth $3,955,000 after buying an additional 13,512 shares during the last quarter. Institutional investors and hedge funds own 90.23% of the company’s stock.

TRADEMARK VIOLATION WARNING: “HCP’s (HCP) “Buy” Rating Reaffirmed at Stifel Nicolaus” was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this piece on another domain, it was stolen and republished in violation of United States and international copyright laws. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2018/02/14/hcp-hcp-price-target-cut-to-27-00.html.

HCP Company Profile

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Analyst Recommendations for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply